Status:
COMPLETED
Deciphering Effects of Thalidomide on Red Blood Cells in Transfusion Dependents Beta Thalassemia Patients
Lead Sponsor:
Blood Care Clinic
Collaborating Sponsors:
Khyber Medical University Peshawar
Conditions:
Transfusion-dependent Beta-Thalassemia
Eligibility:
All Genders
1-18 years
Phase:
PHASE3
Brief Summary
The goal of this Non-Randomized Clinical Trial is to determine the effects of thalidomide on red blood cells in transfusion dependent beta thalassemia patients. The main aims of this study are: * To ...
Detailed Description
Thalassemias are a group of genetic disorder of hemoglobin synthesis characterized by a decreased synthesis of globin chain. Thalassemias are classified as α-,β-, γ-,or δ-thalassemias depending upon t...
Eligibility Criteria
Inclusion
- Diagnosed transfusion dependent β-thalassemia patients
- Possess a verified pre transfusion Hb electrophoresis report performed at age≥ 6 months
Exclusion
- Patients with active metabolic or systemic comorbidities
- Patients with autologous antibodies, AIHA or hypersplenism
Key Trial Info
Start Date :
January 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06146478
Start Date
January 25 2022
End Date
October 31 2023
Last Update
November 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Blood Care Clinic
Peshawar, Khyber Pakhtunkhwa, Pakistan